Search Submit Your Manuscript

Become A Member

  1. Home
  2. October 2023
  3. 26. Use of B-Scan Ultrasonography is Determining the Causes of Low Vision in Patients with Diabetic Retinopathy
Article Image
Admin

26. Use of B-Scan Ultrasonography is Determining the Causes of Low Vision in Patients with Diabetic Retinopathy

Salma Liaqat, Jan Zada and Sher Akbar Khan

ABSTRACT

Objective: The objective of this study is to examine the cause of poor vision in individuals diagnosed with diabetic retinopathy (DR) by the application of B-scan ultrasonography.

Study Design: A prospective study

Place and Duration of Study: This study was conducted at the Department of Opththalmology, Saidu Group of Teaching Hospitals, Swat from August 2022 to August 2023.

Methods: One hundred participants with varying degrees of diabetic retinopathy (DR) were prospectively included in the study. Diabetic patients with poor vision were evaluated using a Nidek ultrasound device to identify the underlying reasons based on their HbA1c as well as ETDRS levels.

Results: In the study of 100 diabetes patients, the main statistics revealed an age range of 14 to 69 years, with 85% males and 15% females. Diabetic retinopathy severity increased with age, diabetes duration, and HbA1c levels. Ultrasound exhibited high sensitivity (97.55%) and specificity (83.61%) in detecting diabetic-related low vision causes, emphasizing its diagnostic significance.

Conclusions: The utilization of B-mode ultrasonography in ophthalmology has proven to be a valuable imaging modality for the identification and assessment of difficulties associated with diabetic retinopathy (DR), which can serve as prognostic indicators for visual outcomes. This approach is characterized by its expeditiousness and noninvasive nature, ensuring little pain for patients during the examination.

Key Words: Low vision, Diabetic retinopathy and B-scan ultrasonography

 

Citation of article: Liaqat S, Zada J, Khan SA. Use of B-Scan Ultrasonography is Determining the Causes of Low Vision in Patients with Diabetic Retinopathy. Med Forum 2023;34(10):120-124. doi:10.60110/medforum.341026.